Characterize and assess clinical outcomes of patients receiving tezepelumab after marketing approval in Spain

Trial Identifier: D5180R00038
Sponsor: AstraZeneca
Start Date: June 2025
Primary Completion Date: December 2025
Study Completion Date: December 2025
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Spain Andalucia, Spain
Spain C. Valenciana, Spain
Spain C. y Leon, Spain
Spain Cantabria, Spain
Spain Cataluna, Spain
Spain Extremadura, Spain
Spain Galicia, Spain
Spain Islas Canarias, Spain
Spain Madrid, Spain
Spain Navarra, Spain
Spain Pais Vasco, Spain